See also this year's filing and all EDGAR filings for this company.
PDF Report 0001423824_2018_Alder_Biopharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001423824, Alder Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 287,254,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,630,000 |
| 3 | remainder_Assets | 10,252,000 |
| 4 | LiabilitiesCurrent | 23,366,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 495,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 68,723,154 |
| 9 | ResearchAndDevelopmentExpense | 853,612,000 |
| 10 | remainder_Expenses | 9,148,999 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 3,398,900 |
| 13 | remainder_ComprehensiveNetIncome | 255,912 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 303,136,000 |
| 1 | Liabilities | 23,861,000 |
| 2 | Expenses | 931,484,153 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 279,275,000 |
| 5 | NetIncome | -928,085,253 |
| 6 | ComprehensiveNetIncome | -927,957,297 |
| 7 | BaseVar | 631,067,982 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.95 |
| 9 | EconomicCapitalRatio | 1.04 |
Edgar->Model Mapping
Feature Distribution
Change over Time
